Swab

Rhinostics and LVL technologies Partner to Provide Decapping Solutions for Automated Collection Device Workflows

Retrieved on: 
Monday, November 14, 2022
Medical Supplies, Biotechnology, Other Health, Health, Oncology, Health Technology, Medical Devices, Research, Infectious Diseases, Genetics, Science, Automation, Workflow, Marketing, Inc., Swab, Genomics, Wyss Institute, Respiratory disease, Biotechnology, Partnership, Laboratory, PCR, Multimedia, Co-promotion, Doctor of Philosophy, Collection, VTM, Cancer, TLM, Biomarker, Research, ELISA, LVL, Harvard University, Genetic testing, SBS, COVID-19, Organization, NGS, STD, Gesellschaft mit beschränkter Haftung, Patient, 3D printing, Pharmaceutical industry, Medical device

By combining the Rhinostics sample collection device ingenuity with decapper technology, laboratories can benefit from an instantly scalable automated swab and small volume blood collection processing workflow.

Key Points: 
  • By combining the Rhinostics sample collection device ingenuity with decapper technology, laboratories can benefit from an instantly scalable automated swab and small volume blood collection processing workflow.
  • View the full release here: https://www.businesswire.com/news/home/20221114005373/en/
    Rhinostics and LVL technologies Partner to Provide Decapping Solutions for Automated Collection Device Workflows (Photo: Business Wire)
    Today, researchers, clinicians, and patients alike expect more when it comes to sample collection and diagnostic workflows from respiratory pathogens, sexually transmitted infections, genetic testing to cancer biomarkers and much more, explained Cheri Walker, PhD, President and CEO of Rhinostics.
  • Were excited to expand our partnership with LVL, our supplier of high-quality collection tubes to Rhinostics during the pandemic and beyond.
  • The LVL decapper instrument is the perfect complement to their consumables, allowing improvements to inefficient swab and blood collection workflows.

Rhinostics Launches the VERIstic™ to Redefine Small Volume Blood Collection

Retrieved on: 
Monday, July 25, 2022
Research, Medical Devices, Hospitals, Genetics, Health Technology, Clinical Trials, Science, Surgery, Biotechnology, Medical Supplies, Other Science, Health, Respiratory disease, CLIA, Genomics, Laboratory, Urine collection device, Doctor of Philosophy, 2D, Swab, STD, STI, Collection, COVID-19, Multimedia, DBS, FDA, Blood, Patient, Genetic testing, Wyss Institute, Microfluidics, No Hassle, PCR, Automation, Harvard University, LAMP, Sintering, Medical device

Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic Collection Device focused on small volume blood collection.

Key Points: 
  • Rhinostics introduces another breakthrough in automated sample collection technologies with the launch of the patent-pending VERIstic Collection Device focused on small volume blood collection.
  • (Photo: Business Wire)
    Were very excited to bring this truly unique and simple innovation to the blood collection market, said Cheri Walker, PhD, President and CEO of Rhinostics.
  • VERIstic is suited for a range of applications including other small volume body fluids, blood monitoring, wound care, clinical trials, and a number of home- or clinic-based sample collection needs.
  • Rhinostics continues to innovate, launching the novel VERIstic Collection Device and with a development pipeline of improved sample collection devices that are purpose-built for their application combined with automation enablement.

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Retrieved on: 
Wednesday, July 14, 2021
Medicine, Natural sciences, Branches of biology, Immunologic tests, Medical tests, Medical terminology, Biochemistry methods, COVID-19 testing, Laboratory techniques, Immunoassay, COVID-19, Swab

For this study, Curebase converted drive-through COVID-19 testing centers in southern California into clinical research sites with its unique decentralized clinical trial software platform and virtual site support model.

Key Points: 
  • For this study, Curebase converted drive-through COVID-19 testing centers in southern California into clinical research sites with its unique decentralized clinical trial software platform and virtual site support model.
  • This process required no physical interaction with patients and enabled hundreds of people to be screened in a few weeks.
  • The SCoV-2 Ag Detect Rapid Test is a patent-pending lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleoprotein antigen in direct nasal swab specimens.
  • The point-of-care test r equires no instrumentation or transport media step and can be performed on-site with results delivered in about 20 minutes.

Inventive Health: COVID-19 Detected in 20 Seconds by Ultra-rapid Mouthwash or Nasal Swab Test Using Spectral Analysis Under MHRA Approval

Retrieved on: 
Thursday, July 8, 2021
Coronaviridae, Health sciences, Sarbecovirus, COVID-19, Occupational safety and health, Public health, Zoonoses, Nasopharyngeal swab, Mouthwash, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome, Swab

These signatures are interpreted using artificial intelligence as either positive or negative for SAR-Cov-2, the virus that causes COVID-19.

Key Points: 
  • These signatures are interpreted using artificial intelligence as either positive or negative for SAR-Cov-2, the virus that causes COVID-19.
  • Samples can be collected using either a nasopharyngeal swab or non-invasive mouthwash solution.
  • The MHRA approval process is being driven by Inventive Health and is currently focused on the nasopharyngeal swab with the mouthwash alternative following soon.
  • All pathogens such as SARS-CoV-2 have a unique high resolution digital signature that can be detected using spectral analysis.

Safeguard DNA Diagnostics Launches Rhinostics Dry Collection Swabs for COVID Testing as Primary Collection Devices for Its Laboratories in the Philippines

Retrieved on: 
Wednesday, June 9, 2021
Science, Biotechnology, Research, Medical Supplies, General Health, Health, Medical devices, Infectious diseases, Natural sciences, Laboratory techniques, Chemistry, Physical sciences, Assay, Biochemistry, Titration, Swab

Safeguard DNA Diagnostics Inc, SDDI, one of the largest chains of infectious disease laboratories in the Philippines, has introduced COVID sample collection using the Rhinostics dry nasal and nasopharyngeal collection swabs.

Key Points: 
  • Safeguard DNA Diagnostics Inc, SDDI, one of the largest chains of infectious disease laboratories in the Philippines, has introduced COVID sample collection using the Rhinostics dry nasal and nasopharyngeal collection swabs.
  • View the full release here: https://www.businesswire.com/news/home/20210609005070/en/
    Rhinostics innovative dry collection swabs offer comfortable nasal or nasoharyngeal collection, dry shipment, and sample concentration for better assay performance.
  • The dry swabs are more robust and offer lower risk for contamination during collection and transport than VTM and saliva collection devices.
  • The Rhinostics suite of collection products are registered as Class I exempt medical devices with the FDA and are available for purchase.

Biomerica’s Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab

Retrieved on: 
Tuesday, May 11, 2021
Anatomy, Branches of biology, Swab, Biology, Biological specimens, Sampling, Anterior nasal, Human nose, Laboratory techniques, Nasopharyngeal swab

This simple nasal swab, which takes the sample from the front opening of the nose, is less invasive and more comfortable for patients than the deep anterior nasal swab which is typically used.

Key Points: 
  • This simple nasal swab, which takes the sample from the front opening of the nose, is less invasive and more comfortable for patients than the deep anterior nasal swab which is typically used.
  • The test is highly portable, cost effective and provides visual results negating the need for any equipment to perform or read the test.
  • Our nasal swab test is simple to use, accurate and portable.\xe2\x80\x9d\nMr.
  • A simple nasal swab is used to collect specimens from people suspected of having an active infection.

Rhinostics Exclusively Licenses Innovative Product Brands’ GrooveSwab™, a Novel Nasopharyngeal Swab Designed to Improve Assay Results for COVID-19 and Respiratory Pathogen Testing

Retrieved on: 
Tuesday, May 11, 2021
Science, Other Science, Practice Management, Research, Medical Supplies, Health, Medical devices, Clinical trials, Laboratory techniques, Natural sciences, Chemistry, Physical sciences, Nasopharyngeal swab, Respiratory therapy, Swab, COVID-19, Assay

b"Rhinostics announced that it has exclusively licensed a novel nasopharyngeal swab from Innovative Product Brands, Inc. (IPB) to bring to the clinical laboratory market.

Key Points: 
  • b"Rhinostics announced that it has exclusively licensed a novel nasopharyngeal swab from Innovative Product Brands, Inc. (IPB) to bring to the clinical laboratory market.
  • IPB developed the swab to bring creative solutions to bear on the challenges facing laboratories and supply chains during the COVID-19 pandemic.\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210511005010/en/\nRhinostics' GrooveSwab\xe2\x84\xa2 nasopharyngeal swab brings comfortable collection, dry transport, sample concentration and better assay performance to COVID-19 assays.\n\xe2\x80\x9cWe are excited to license our GrooveSwab\xe2\x84\xa2 nasopharyngeal swab to Rhinostics to take to market.
  • The RHINOstic product is registered as Class I exempt medical device with the FDA and is available for purchase.

Technimark Will Manufacture and Package Innovative Nasal Swabs to Support Medical Community

Retrieved on: 
Thursday, May 6, 2021
Medical Supplies, Biotechnology, Other Consumer, Health, General Health, Pharmaceutical, Medical devices, Research, Infectious diseases, Consumer, Science, Swab, Biological specimens, Medical diagnosis, Polypropylene, Medical laboratory, Sampling, Chemistry, Materials, Biology, Technimark, Rhinostics, iMFLUX, TECHNIMARK, RHINOSTICS, IMFLUX

(Photo: Business Wire)\niMFLUX developed a novel fully injection-molded polypropylene nasal swab that P&G and iMFLUX licensed to Rhinostics to bring to the clinical laboratory market.

Key Points: 
  • (Photo: Business Wire)\niMFLUX developed a novel fully injection-molded polypropylene nasal swab that P&G and iMFLUX licensed to Rhinostics to bring to the clinical laboratory market.
  • \xe2\x80\x9cProduction of the medical-grade polypropylene nasal swabs began in April at Technimark\xe2\x80\x99s headquarters in Asheboro.
  • The Rhinostics nasal swab provides features that increase sample throughput by more than 10-fold while removing labor and errors from the laboratory workflow.
  • The Rhinostics product is registered as Class I exempt medical device with the FDA and is available for purchase.

Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass. startup Rhinostics

Retrieved on: 
Tuesday, May 4, 2021
Wyss Institute, Biological specimens, Sampling, Swab, Wyss, Organizations, Articles, Institutes

b'BOSTON, May 4, 2021 /PRNewswire/ --The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\'s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.

Key Points: 
  • b'BOSTON, May 4, 2021 /PRNewswire/ --The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\'s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.
  • "We were trying to circumvent supply and performance limitations of swabs when I heard about the Wyss Institute\'s swab technology at a MASS CPR online event.
  • Novak had independently thought about possibilities to solve the problem of automatically removing the swab from the sample collection device.
  • The RHINOstic product is registered as Class I exempt medical device with the FDA and is available for purchase.

Harvard University licenses its nasal swab collection technology, developed at the Wyss Institute and Harvard Medical School, to Mass. startup Rhinostics

Retrieved on: 
Tuesday, May 4, 2021
University, Pharmaceutical, Education, Other Consumer, Medical devices, Infectious diseases, Hospitals, General Automotive, Science, Biotechnology, Automotive, Consumer, Health, Research, Medical Supplies, Wyss Institute, Swab, Sampling, Decap, Automation

b'The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\xe2\x80\x99s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.

Key Points: 
  • b'The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University\xe2\x80\x99s sample collection swab and high-throughput automation technologies have been licensed to Rhinostics.
  • Bringing comfortable collection, dry shipment, new materials, sample concentration, rapid accessioning, and automated decapping to laboratory workflows.
  • Novak had independently thought about possibilities to solve the problem of automatically removing the swab from the sample collection device.
  • The RHINOstic product is registered as Class I exempt medical device with the FDA and is available for purchase.